Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.

@article{Johnson2010EscherichiaCS,
  title={Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.},
  author={James R. Johnson and Andrew William. Johnston and Connie Clabots and Michael A. Kuskowski and Elisabete M. S. Castanheira},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2010},
  volume={51 3},
  pages={
          286-94
        }
}
BACKGROUND Escherichia coli sequence type ST131 (O25:H4), associated with the CTX-M-15 extended-spectrum beta-lactamase, has emerged internationally as a multidrug-resistant pathogen but has received little attention in the United States. METHODS From the SENTRY and Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) surveillance programs, 127 E. coli clinical isolates from hospitalized patients across the United States in 2007, stratified by extended-spectrum cephalosporin… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 227 CITATIONS

FILTER CITATIONS BY YEAR

2011
2019

CITATION STATISTICS

  • 25 Highly Influenced Citations

  • Averaged 21 Citations per year over the last 3 years

References

Publications referenced by this paper.
SHOWING 1-10 OF 28 REFERENCES

Escherichia coli pyomyositis: an emerging entity among patients with hematologic malignancies

  • KJ Vigil, JR Johnson, B Johnston
  • Clin Infect Dis
  • 2010
Highly Influential
13 Excerpts

First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system

  • JS Lewis
  • Antimicrob Agents Chemother
  • 2007
Highly Influential
12 Excerpts

Similar Papers

Loading similar papers…